Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its 2026 revenue growth outlook.

Thermo’s Q2 performance was driven by its laboratory products and biopharma services business with profits around $6.69bn equating to a 12% uptick YoY.

Affinity Technologies has collaborated with Pictor to develop and commercialise new diagnostic tests for asthma and COPD.

While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.

Following TYBR’s B3 GEL’s US launch in January 2026, the company primarily intends to use the funds to expand market access to the hydrogel.

Health technology brand Hilo, developed by Aktiia, has launched its Hilo Core blood pressure monitoring system in the US.

Cardinal Health’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.

Fresenius Medical Care has introduced TherapyWise, a cloud-based analytics platform aimed at supporting hospital and critical care teams overseeing KRT in the US.

The multiple myeloma assay will assess 18 markers in a single tube, which reduces the required specimen volume. Credit: luchschenF / Shutterstock.com. ARUP Laboratories has launched the clinical ...

GE HealthCare's tool is intended to streamline imaging workflow collaboration between different specialist teams in areas such as oncology.

BRIJ Medical’s incision management options are used by plastic and orthopaedic surgeons. Credit: photoshooter2015 / Shutterstock.com. BRIJ Medical has commercially launched BRIJ-SEAL, a wound sealant ...